MARC Record from Library of Congress

LEADER: 02977nam a22003258a 4500
001 2011038744
003 DLC
005 20110928123435.0
008 110914s2012 enk 000 0 eng
010 $a 2011038744
020 $a9781107004641
040 $aDLC$cDLC
042 $apcc
050 00 $aRG135$b.V36 2012
082 00 $a618.178059900223$223
084 $aMED033000$2bisacsh
100 1 $aVan den Bergh, Marc.
245 10 $aAtlas of oocytes, zygotes and embryos in reproductive medicine /$cMarc Van den Bergh, Kay Elder, Thomas Ebner.
260 $aCambridge ;$aNew York :$bCambridge University Press,$c2012.
263 $a1203
300 $ap. cm.
520 $a"The assessment and selection of oocytes and embryos is fundamental to the live birth rate data of all IVF units, the parameter that is used to gauge a clinic's success and credibility. This new atlas contains over 1000 high-quality images of oocytes, zygotes and embryos, presented with accompanying data on indications for treatment, stimulation type and duration, as well as short medical histories of each couple and final outcome of treatment. All images in the book can be downloaded from the accompanying CD-ROM. Structured on a patient-by-patient basis, the atlas describes 100 clinically documented case studies that follow the evolution of oocytes and zygotes between day two and day five. Pronuclear morphology and synchrony as well as embryo morphology are reported and described for each case. Written and produced by experienced embryologists, this practical atlas is an important resource for clinical embryologists and physicians in reproductive medicine"--$cProvided by publisher.
505 8 $aMachine generated contents note: Introduction; Female indications for treatment; Clinical and laboratory protocols; Controlled ovarian hyperstimulation; Sperm preparation; ICSI; In vitro culture system; Oocyte and embryo assessment; Case histories: Part I. 'KSB': Cleavage Stage Transfer (Case Numbers 1-80): 1. No female indication identified (cases 1-33); 2. Tubal infertility (cases 34-40); 3. Cervical hostility/fibroids (cases 41-44); 4. Endometriosis (cases 45-60); 5. Poor responder or ovulatory dysfunction (cases 61-71); 6. Polycystic ovarian disease (cases 72-74); 7. Hyperprolactinaemia/Hypothyroid (cases 75-79); 8. Recurrent abortion (case 80); Part II. 'Linz': Extended Culture to Blastocyst Stage (Case Numbers 81-111): 9. No female indication identified (cases 81-92); 10. Unexplained, failed IVF (cases 93-94); 11. Tubal infertility (cases 95-98); 12. Endometriosis (cases 99-102); 13. Polycystic ovarian disease (cases 103-109); 14. Premature ovarian failure (case 110); 15. Translocation (case 111).
650 0 $aFertilization in vitro, Human$vAtlases.
650 0 $aOvum$vAtlases.
650 0 $aZygotes$vAtlases.
650 0 $aHuman embryo$vAtlases.
650 7 $aMEDICAL / Gynecology & Obstetrics.$2bisacsh
700 1 $aElder, Kay,$d1946-
700 1 $aEbner, Thomas.